The Company
Who we are

NanoLockin

NanoLockin is an early-stage startup company developing instruments for the detection and analysis of nanoparticles in all kinds of products. As a spin-off from the Adolphe Merkle Institute - an institution which specializes on nanomaterials research - the team of NanoLockin has long lasting expertise in the analysis of nanomaterials.

Meet our Team

Founded in 2018 by four people, our team currently consists of the following people.

Dr Christoph Geers
CEO & Co-founder

Christoph is responsible for the technical, application and business development. He has a strong technical background in a variety of different fields (Biotechnology, Chemistry, Material Sciences & Biomedical Engineering) and is highly experienced in the field of nanoparticle analytics.

Olivier Schaub
Instrumentation & control engineer

Olivier completed successfully his studies at the HEIA-FR (Haute école d'ingénierie et d'architecture de Fribourg) and obtained his Bachelor's degree in electrical engineering. He has skills in hardware and software development. He is responsible for all the technical aspects.

Bihter Geers
Administration

Bihter is the main responsible for all administrative aspects including finance and human resources. Bihter has a background in business management and several years of experience in human resources business administration.

Dr Mathias Bonmarin
Co-Founder

Mathias supports the CEO in technical related aspects regarding the prototype development and its industrialisation. Mathias has more than 10 years of experience in infrared and thermal imaging and has led numerous successful projects in collaboration with the industry.

Prof Dr Gunter Festel
Co-Founder

Gunter supports the CEO in all business-related aspects like business development and the acquisition of financial resources. Gunter has a deep understanding of scientific and business aspects due to 20 years of experience in technology development, both in big companies and startups.

Advisory Board

To help us on our journey, we are very happy to have the following world-class experts in our advisory board.

Prof Dr Barbara Rothen-Rutishauser
Scientific Advisor

Prof. Rothen-Rutishauser is a leading scientist in the field of nanoparticle hazard and risk assessment, with a background in cell biology. She is a pioneer in the field of the next generation development of in vitro alternatives to study the interaction of NPs with human tissues. She has a proven track record of successful collaborations with implementation partners, ranging from regulatory bodies, federal agencies to industry partners. The engagement in application-oriented research has been recognized and funded by numerous grants as well as with several prestigious prices.